Will the Cannabis Industry Make Gains For The End Of The Year?…

The post Will These Marijuana Stocks To Watch Rebound In 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Aleafia Health Launches Cannabis 2.0 Portfolio with 510 Vape Cartridges Featuring Unique Formulations
For Investor & Media Relations: Nicholas Bergamini, VP Investor Relations1-833-879-2533LEARN MORE: www.AleafiaHealth.com About Aleafia Health: Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production... Read more
Hyasynth first to market with CBD in global race to commercialize cannabinoids produced using microbial biosynthesis
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more

Leafbuyer Technologies, Inc. Posts 41% Year Over Year Revenue Growth Leafbuyer Technologies,…

The post Leafbuyer Technologies, Inc. (LBUY) Posts 41% Year Over Year Revenue Growth appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more

Can These Leading Pot Stocks Build More Momentum Before Next Year? 2020…

The post 3 Marijuana Stocks to Hold For The End Of 2020 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more

These Alternative Marijuana Stocks May be Winners This October   When it…

The post Will These Top Pot Stocks See More Gains Next Month? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Cardiol Therarpeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III COVID-19 Trial
Ryan Allway September 25th, 2020 News, Top News Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease (CVD) Oakville, Ontario–(Newsfile Corp. – September 25, 2020) – Cardiol... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )